Accordingly, the combinatorial administration of the anti-IL10 mAb, but not its related isotypic control (not shown), to gp10025-33 peptide-pulsed DC vaccinated mice led to a complete protection from B16F10 melanoma growth (Figure 6). Here, IL10 is linked to melanoma.